Expression of ILK and PKB/Akt in acute leukemia and its significance.
10.7534/j.issn.1009-2137.2013.01.004
- Author:
Ting SUN
1
;
Hui SUN
;
Jie MA
;
Yan-Fang LIU
;
Gui-Ye WANG
;
Cai-Ying ZUO
Author Information
1. Department of Hematology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Bone Marrow Cells;
metabolism;
Female;
Humans;
Leukemia;
metabolism;
pathology;
Male;
Middle Aged;
Protein-Serine-Threonine Kinases;
metabolism;
Proto-Oncogene Proteins c-akt;
metabolism;
RNA, Messenger;
genetics;
Young Adult
- From:
Journal of Experimental Hematology
2013;21(1):16-19
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this study was to investigate the expression of integrin linked kinase (ILK) and protein kinase B (PKB/Akt) in acute leukemia (AL), explore the possible effects of ILK/Akt pathway on AL pathogenesis. The expression level of ILK mRNA and Akt mRNA in different types and stages of AL bone marrow mononuclear cells was detected by reverse transcription polymerase chain reaction (RT-PCR). The results showed that the expression of ILK and Akt in do nove AL group was higher than that in AL-CR group and normal control group (P < 0.05), while there was no statistically difference between de nove AL and relapsed AL groups (P > 0.05). The expression of ILK positively correlates with Akt expression in de nove AL group (P < 0.05). It is concluded that the expression of ILK and Akt mRNA is abnormally higher in AL, ILK/Akt pathway may be involved in the pathogenesis and progression of AL and may be a potential therapeutic target for AL.
